首页 > 最新文献

International Journal of Organ Transplantation Medicine最新文献

英文 中文
Post-transplantation Presentation of ANCA-associated Vasculitis: Granulomatosis with Polyangitis. 移植后anca相关血管炎的表现:肉芽肿病伴多血管炎。
IF 0.7 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-11-01
M A Shafiee, G Parastandechehr, S Taba Taba Vakili, M Shahroukh, A Haghighi, B Broumand

Granulomatosis with polyangitis (GPA) is characterized by necrotizing granulomatosis of the upper and lower respiratory tract and glomerulonephritis. If GPA does not respond to appropriate management, it might result in end-stage renal disease, which may remit the disease severity. The overall impression is that immunosuppression following renal transplantation would further subside the vasculitis. However, several studies have shown that systemic vasculitis recur in 25% of patients following renal transplantation. This may indicate the perplexing nature of the immune system. One of the key factors in prevention of relapse of GPA is following up of patients by careful immunosuppressive dose adjustment and regular measurement of biomarkers for vasculitis. Herein, we describe an interesting case of biopsy-proven GPA who had a complex long history of several post-transplantation relapses in different organs with anti-neutrophil cytoplasmic antibodies seroconversion. This case emphasizes that vasculitis in particular GPA can mimic various diseases depending on which vessels and organs are affected by the inflammation and is one of the reversible causes of failure of transplanted kidney. Bearing the diagnosis in mind as one of the potential differential diagnoses of failure of renal transplantation will lead to early diagnosis and treatment of recurrent GPA.

多血管炎肉芽肿病(GPA)的特点是上呼吸道和下呼吸道坏死性肉芽肿病和肾小球肾炎。如果GPA没有得到适当的治疗,可能会导致终末期肾脏疾病,这可能会减轻疾病的严重程度。总的印象是,肾移植后的免疫抑制将进一步缓解血管炎。然而,一些研究表明,25%的肾移植术后患者会复发全身性血管炎。这可能表明了免疫系统令人困惑的本质。预防GPA复发的关键因素之一是通过仔细调整免疫抑制剂量和定期测量血管炎的生物标志物对患者进行随访。在此,我们描述了一个有趣的活组织检查证实的GPA病例,他有几个移植后不同器官复发的复杂的长期历史,并伴有抗中性粒细胞细胞质抗体血清转化。这个病例强调血管炎,特别是GPA,可以模仿各种疾病,这取决于受炎症影响的血管和器官,是移植肾衰竭的可逆原因之一。将诊断作为肾移植失败的潜在鉴别诊断之一,将有助于早期诊断和治疗复发性GPA。
{"title":"Post-transplantation Presentation of ANCA-associated Vasculitis: Granulomatosis with Polyangitis.","authors":"M A Shafiee,&nbsp;G Parastandechehr,&nbsp;S Taba Taba Vakili,&nbsp;M Shahroukh,&nbsp;A Haghighi,&nbsp;B Broumand","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Granulomatosis with polyangitis (GPA) is characterized by necrotizing granulomatosis of the upper and lower respiratory tract and glomerulonephritis. If GPA does not respond to appropriate management, it might result in end-stage renal disease, which may remit the disease severity. The overall impression is that immunosuppression following renal transplantation would further subside the vasculitis. However, several studies have shown that systemic vasculitis recur in 25% of patients following renal transplantation. This may indicate the perplexing nature of the immune system. One of the key factors in prevention of relapse of GPA is following up of patients by careful immunosuppressive dose adjustment and regular measurement of biomarkers for vasculitis. Herein, we describe an interesting case of biopsy-proven GPA who had a complex long history of several post-transplantation relapses in different organs with anti-neutrophil cytoplasmic antibodies seroconversion. This case emphasizes that vasculitis in particular GPA can mimic various diseases depending on which vessels and organs are affected by the inflammation and is one of the reversible causes of failure of transplanted kidney. Bearing the diagnosis in mind as one of the potential differential diagnoses of failure of renal transplantation will lead to early diagnosis and treatment of recurrent GPA.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 4","pages":"184-191"},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37224696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Product Transfusion in Liver Transplantation and its Impact on Short-term Survival. 肝移植输血对短期生存的影响。
IF 0.7 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-08-01
L Kasraian, S Nikeghbalian, M H Karimi

Background: Estimation of the amount of blood products required during liver transplantation can help provision of adequate blood supply, minimize transfusion-associated complications, and plan for preventive measures in high risk patients.

Objective: To investigate independent predictors of peri-operative blood product transfusion and its impact on short-term survival of liver transplant recipients.

Methods: In a cross-sectional study, old charts of patients who underwent liver transplantation between March 2003 and March 2013 at Namazi Hospital, Shiraz, Iran, were reviewed. The mean amount of blood product utilized during surgery and hospital stay and the related factors, including demographic characteristics, pre-transplant laboratory data, pre-transplant clinical data, operation data, and post-transplantation data were recorded.

Results: We studied 1198 patients who underwent liver transplantation. The mean±SD amounts of red blood cells, fresh frozen plasma, and platelet transfusion during surgery and hospital stay were 2.67±3.5, 2.06±3.8, and 1.6±3.8 units, respectively. The mortality rate was significantly higher in patients who received high amounts of blood products (p<0.001). The mean amount of blood products' utilized during operation was significantly (p<0.001) decreased from 2003 to 2013.The mean amount of packed cell usage during operation and hospital stay was significantly (p<0.001) correlated with age, technique of surgery, serum albumin level, cirrhosis, blood urea nitrogen, length of operation, and prothrombin time.

Conclusion: Pre-operative factors may predict blood transfusion requirements in patients undergoing liver transplantation. Therefore, evaluation of patients before operation should be considered to provide adequate blood supply and minimize transfusion-associated complications. Understanding pre-operative factors associated with rate of transfusion may help us to best utilize the limited available blood resources.

背景:估计肝移植过程中所需血液制品的数量有助于提供充足的血液供应,减少输血相关并发症,并为高危患者制定预防措施。目的:探讨肝移植受者围手术期输血的独立预测因素及其对短期生存的影响。方法:在一项横断面研究中,回顾了2003年3月至2013年3月在伊朗设拉子Namazi医院接受肝移植的患者的旧图表。记录手术期间和住院期间血液制品的平均使用量及其相关因素,包括人口统计学特征、移植前实验室数据、移植前临床数据、手术数据和移植后数据。结果:我们研究了1198例肝移植患者。手术和住院期间红细胞、新鲜冷冻血浆和血小板输注平均±SD分别为2.67±3.5、2.06±3.8和1.6±3.8单位。结论:术前因素可预测肝移植患者的输血需求。因此,术前评估患者应考虑提供充足的血液供应,尽量减少输血相关并发症。了解与输血率相关的术前因素可以帮助我们更好地利用有限的可用血液资源。
{"title":"Blood Product Transfusion in Liver Transplantation and its Impact on Short-term Survival.","authors":"L Kasraian,&nbsp;S Nikeghbalian,&nbsp;M H Karimi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Estimation of the amount of blood products required during liver transplantation can help provision of adequate blood supply, minimize transfusion-associated complications, and plan for preventive measures in high risk patients.</p><p><strong>Objective: </strong>To investigate independent predictors of peri-operative blood product transfusion and its impact on short-term survival of liver transplant recipients.</p><p><strong>Methods: </strong>In a cross-sectional study, old charts of patients who underwent liver transplantation between March 2003 and March 2013 at Namazi Hospital, Shiraz, Iran, were reviewed. The mean amount of blood product utilized during surgery and hospital stay and the related factors, including demographic characteristics, pre-transplant laboratory data, pre-transplant clinical data, operation data, and post-transplantation data were recorded.</p><p><strong>Results: </strong>We studied 1198 patients who underwent liver transplantation. The mean±SD amounts of red blood cells, fresh frozen plasma, and platelet transfusion during surgery and hospital stay were 2.67±3.5, 2.06±3.8, and 1.6±3.8 units, respectively. The mortality rate was significantly higher in patients who received high amounts of blood products (p<0.001). The mean amount of blood products' utilized during operation was significantly (p<0.001) decreased from 2003 to 2013.The mean amount of packed cell usage during operation and hospital stay was significantly (p<0.001) correlated with age, technique of surgery, serum albumin level, cirrhosis, blood urea nitrogen, length of operation, and prothrombin time.</p><p><strong>Conclusion: </strong>Pre-operative factors may predict blood transfusion requirements in patients undergoing liver transplantation. Therefore, evaluation of patients before operation should be considered to provide adequate blood supply and minimize transfusion-associated complications. Understanding pre-operative factors associated with rate of transfusion may help us to best utilize the limited available blood resources.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 3","pages":"105-111"},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36716493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Aortic Root Replacement and Heart Transplantation in a Patient with Dilated Cardiomyopathy and Aortic Root Aneurysm. 主动脉根部置换联合心脏移植治疗扩张型心肌病合并主动脉根部动脉瘤1例。
IF 0.7 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-08-01
B Baharestani, A Amin, B Ghadrdoost, M Behjati

Concomitant replacement of the ascending aorta and heart transplantation are an infrequent procedure. This procedure was most often performed in patients with Marfan syndrome, however, it has its own technical difficulties. Hereby, we report on combined heart transplantation and aortic root replacement using donor's ascending aorta in a 25-year-old man diagnosed with dilated cardiomyopathy and ascending aorta aneurysm. This procedure was successful and beneficial to patients with aortopathy who are candidates for heart transplantation.

同时进行升主动脉置换和心脏移植是一种罕见的手术。这种手术最常用于马凡氏综合征患者,然而,它有自己的技术困难。在此,我们报告一名25岁男性,诊断为扩张型心肌病和升主动脉动脉瘤,采用供体升主动脉联合心脏移植和主动脉根置换。这一过程是成功的,有利于主动脉病变患者谁是心脏移植的候选人。
{"title":"Combined Aortic Root Replacement and Heart Transplantation in a Patient with Dilated Cardiomyopathy and Aortic Root Aneurysm.","authors":"B Baharestani,&nbsp;A Amin,&nbsp;B Ghadrdoost,&nbsp;M Behjati","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Concomitant replacement of the ascending aorta and heart transplantation are an infrequent procedure. This procedure was most often performed in patients with Marfan syndrome, however, it has its own technical difficulties. Hereby, we report on combined heart transplantation and aortic root replacement using donor's ascending aorta in a 25-year-old man diagnosed with dilated cardiomyopathy and ascending aorta aneurysm. This procedure was successful and beneficial to patients with aortopathy who are candidates for heart transplantation.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 3","pages":"137-139"},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36716498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Results of Kidney Transplantation from Expanded Criteria Donors: A Single-Center Experience. 扩大标准供者肾移植的结果:单中心经验。
IF 0.7 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-02-01
B Palkoci, M Vojtko, J Fialová, D Osinová, M Lajčiaková

Background: Collection of kidneys from extended criteria donors (ECD) with diagnosed brain-death forms a part of the collection program that increases the number of transplantations.

Objective: To compare the results of ECD with those of standard criteria donors (SCD).

Methods: In a retrospective analysis in a group of 156 kidney donors, we identified ECD donors. We detected the basic parameters of the donors before kidney collection, and then evaluated the function of the graft, the survival of the graft, and the survival of the patients after 1, 3, and 5 years of transplantation. The results were then compared with the function of the graft from those of SCD donors.

Results: The ECD donors were significantly (p<0.001) older than the SCD donors. They had a higher body mass index (p=0.006) and prevalence of hypertension (p<0.001) and diabetes mellitus (p=0.004) compared to SCD donors. The graft function within the first 6 months and the survival of recipients in the first year of transplantation were significantly worse in ECD than in SCD groups (p=0.01, and 0.023, respectively). No difference in the graft survival was observed between the two groups.

Conclusion: The long-term function of the graft and survival of patients and grafts in recipients of kidneys from ECD donors are comparable to SCD donors. Exploitation of the given organs for transplantation is important due to the constantly increasing demand versus limited offer of organs.

背景:从诊断为脑死亡的扩展标准供体(ECD)收集肾脏是增加移植数量的收集计划的一部分。目的:比较ECD与标准供体(SCD)的结果。方法:在一组156肾供者的回顾性分析中,我们确定了ECD供者。我们在取肾前检测供者的基本参数,然后评估移植物的功能、移植物的存活,以及移植后1年、3年和5年患者的存活。然后将结果与来自SCD供体的移植物的功能进行比较。结果:ECD供者与SCD供者肾脏移植的远期功能及患者和移植肾的存活相当。由于需求不断增加而器官供应有限,利用特定器官进行移植是很重要的。
{"title":"Results of Kidney Transplantation from Expanded Criteria Donors: A Single-Center Experience.","authors":"B Palkoci,&nbsp;M Vojtko,&nbsp;J Fialová,&nbsp;D Osinová,&nbsp;M Lajčiaková","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Collection of kidneys from extended criteria donors (ECD) with diagnosed brain-death forms a part of the collection program that increases the number of transplantations.</p><p><strong>Objective: </strong>To compare the results of ECD with those of standard criteria donors (SCD).</p><p><strong>Methods: </strong>In a retrospective analysis in a group of 156 kidney donors, we identified ECD donors. We detected the basic parameters of the donors before kidney collection, and then evaluated the function of the graft, the survival of the graft, and the survival of the patients after 1, 3, and 5 years of transplantation. The results were then compared with the function of the graft from those of SCD donors.</p><p><strong>Results: </strong>The ECD donors were significantly (p<0.001) older than the SCD donors. They had a higher body mass index (p=0.006) and prevalence of hypertension (p<0.001) and diabetes mellitus (p=0.004) compared to SCD donors. The graft function within the first 6 months and the survival of recipients in the first year of transplantation were significantly worse in ECD than in SCD groups (p=0.01, and 0.023, respectively). No difference in the graft survival was observed between the two groups.</p><p><strong>Conclusion: </strong>The long-term function of the graft and survival of patients and grafts in recipients of kidneys from ECD donors are comparable to SCD donors. Exploitation of the given organs for transplantation is important due to the constantly increasing demand versus limited offer of organs.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 1","pages":"1-9"},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839624/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35906670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation. 移植时接受抗血小板治疗的肾移植受者一年同种异体移植和患者生存率。
IF 0.7 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-02-01
T Benkö, M Gottmann, S Radunz, A Bienholz, F H Saner, J W Treckmann, A Paul, D P Hoyer

Background: Antiplatelet therapy is common in patients on the waiting list for kidney transplantation.

Objective: To evaluate the incidence of post-operative bleeding in patients with antiplatelet therapy undergoing kidney transplantation and analyze the impact on the outcome.

Methods: We studied all patients with concomitant antiplatelet therapy undergoing kidney transplantation in our center from January 2007 to June 2012. Data were collected by chart review. Univariate and multivariate logistic regression and Cox proportional hazard model were used to identify risk factors for the long-term outcome.

Results: Of 744 kidney transplant recipients during the study period, 161 received oral antiplatelet therapy and were included in the study. One-third of the patients demonstrated signs of bleeding, half of which requiring surgical treatment. Coronary artery disease, deceased donor kidney transplantation, and dual antiplatelet medication were independent risk factors for post-operative bleeding. One-year allograft survival was significantly better in the non-bleeding group (91.4% vs 75.9%, p=0.023). Multivariable analysis found that post-operative bleeding, recipient age, and biopsy-proven rejection were independent risk factors for graft survival. Recipient age and biopsy-proven rejection were also identified as independent risk factors for patient survival.

Conclusion: This analysis indicated a high risk for post-operative bleeding in renal transplant patients under antiplatelet therapy. The associated negative effect on allograft survival underscored the need to reduce any risk factors for post-operative bleeding.

背景:抗血小板治疗在等待肾移植的患者中很常见。目的:评价肾移植术后接受抗血小板治疗的患者术后出血的发生率,并分析其对预后的影响。方法:对2007年1月至2012年6月在我中心接受肾移植同时抗血小板治疗的患者进行研究。通过图表回顾收集数据。采用单因素和多因素logistic回归及Cox比例风险模型确定影响长期预后的危险因素。结果:在研究期间的744例肾移植受者中,有161例接受了口服抗血小板治疗,并被纳入研究。三分之一的患者表现出出血的迹象,其中一半需要手术治疗。冠状动脉疾病、死亡供肾移植和双重抗血小板药物是术后出血的独立危险因素。非出血组一年同种异体移植存活率显著提高(91.4% vs 75.9%, p=0.023)。多变量分析发现,术后出血、受体年龄和活检证实的排斥反应是移植物存活的独立危险因素。受体年龄和活检证实的排斥反应也被确定为患者生存的独立危险因素。结论:本分析提示肾移植术后接受抗血小板治疗的患者出血风险高。对同种异体移植存活的相关负面影响强调了减少术后出血的任何危险因素的必要性。
{"title":"One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation.","authors":"T Benkö,&nbsp;M Gottmann,&nbsp;S Radunz,&nbsp;A Bienholz,&nbsp;F H Saner,&nbsp;J W Treckmann,&nbsp;A Paul,&nbsp;D P Hoyer","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Antiplatelet therapy is common in patients on the waiting list for kidney transplantation.</p><p><strong>Objective: </strong>To evaluate the incidence of post-operative bleeding in patients with antiplatelet therapy undergoing kidney transplantation and analyze the impact on the outcome.</p><p><strong>Methods: </strong>We studied all patients with concomitant antiplatelet therapy undergoing kidney transplantation in our center from January 2007 to June 2012. Data were collected by chart review. Univariate and multivariate logistic regression and Cox proportional hazard model were used to identify risk factors for the long-term outcome.</p><p><strong>Results: </strong>Of 744 kidney transplant recipients during the study period, 161 received oral antiplatelet therapy and were included in the study. One-third of the patients demonstrated signs of bleeding, half of which requiring surgical treatment. Coronary artery disease, deceased donor kidney transplantation, and dual antiplatelet medication were independent risk factors for post-operative bleeding. One-year allograft survival was significantly better in the non-bleeding group (91.4% <i>vs</i> 75.9%, p=0.023). Multivariable analysis found that post-operative bleeding, recipient age, and biopsy-proven rejection were independent risk factors for graft survival. Recipient age and biopsy-proven rejection were also identified as independent risk factors for patient survival.</p><p><strong>Conclusion: </strong>This analysis indicated a high risk for post-operative bleeding in renal transplant patients under antiplatelet therapy. The associated negative effect on allograft survival underscored the need to reduce any risk factors for post-operative bleeding.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 1","pages":"10-19"},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839625/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35906671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recipients' Experiences after Organ Transplantation. 器官移植后受者的感受。
IF 0.7 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-05-01
Z Sheikhalipour, V Zamanzadeh, L Borimnejad, L Valizadeh, M Shahbazi, A Zomorrodi, M Nazari

Background: After organ transplantation, many patients have diverse experiences; they face many changes in the physical and emotional aspects of their life. Patients' understandings of the post-transplantation period influence their adaptation to the changes. There is a need to improving the knowledge of patients' unique experiences of post-transplantation period and the changes occur in their life.

Objective: To explore the experiences of organ recipients in the post-transplantation period.

Methods: In a qualitative research using a hermeneutical phenomenological approach, data were collected from April 2015 to June 2016. Participants were consisted of 15 patients who received organ chosen using a purposive sampling method. In-depth semi-structured interviews were held with them. The collected data were analyzed using Diekelmann's hermeneutical analysis approach.

Results: The data analyses led to the development of 3 main themes and 17 subthemes as "back from the grave" with the subthemes of "organ as the God's deposit," "God as the source of life," and "new life"; "chapter of prosperity" with the subthemes of "the spring of the body," "recovery," "peace and joy," "benevolent and good behavior," "renewal," "opportunity of being together again," "golden age," "positive perspective," "the sense of normality," "the return of health," and "spiritual evolution"; and "the fall" with the subthemes of "a lack of energy," "the mirage of transplantation," and "hell on the earth."

Conclusion: The patients had diverse experiences of the post-transplantation period, which varied from the feeling of exhilaration and youth to losing energy and the wish for not undertaking organ transplantation.

背景:器官移植后,许多患者有不同的经历;他们面临着生活中身体和情感方面的许多变化。患者对移植后时期的认识影响其对变化的适应。有必要提高对移植后患者独特经历及其生活变化的认识。目的:探讨器官移植后受者的体会。方法:2015年4月至2016年6月,采用解释学现象学方法进行定性研究。参与者包括15名接受器官选择的患者,采用有目的的抽样方法。我们与他们进行了深入的半结构化访谈。收集的数据使用Diekelmann的解释学分析方法进行分析。结果:通过数据分析,形成了“从坟墓中复活”的3个主题和17个副主题,其中“器官是上帝的沉积物”、“上帝是生命的源泉”、“新生命”等副主题;“繁荣篇章”的副主题是“身体的春天”、“康复”、“和平与快乐”、“仁慈和良好的行为”、“更新”、“再次相聚的机会”、“黄金时代”、“积极的观点”、“正常的感觉”、“健康的回归”和“精神进化”;《堕落》的副主题是“缺乏活力”、“移植的海市蜃楼”和“人间地狱”。结论:移植后患者有不同的经历,从兴奋、青春到失去活力、不愿进行器官移植。
{"title":"Recipients' Experiences after Organ Transplantation.","authors":"Z Sheikhalipour,&nbsp;V Zamanzadeh,&nbsp;L Borimnejad,&nbsp;L Valizadeh,&nbsp;M Shahbazi,&nbsp;A Zomorrodi,&nbsp;M Nazari","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>After organ transplantation, many patients have diverse experiences; they face many changes in the physical and emotional aspects of their life. Patients' understandings of the post-transplantation period influence their adaptation to the changes. There is a need to improving the knowledge of patients' unique experiences of post-transplantation period and the changes occur in their life.</p><p><strong>Objective: </strong>To explore the experiences of organ recipients in the post-transplantation period.</p><p><strong>Methods: </strong>In a qualitative research using a hermeneutical phenomenological approach, data were collected from April 2015 to June 2016. Participants were consisted of 15 patients who received organ chosen using a purposive sampling method. In-depth semi-structured interviews were held with them. The collected data were analyzed using Diekelmann's hermeneutical analysis approach.</p><p><strong>Results: </strong>The data analyses led to the development of 3 main themes and 17 subthemes as \"back from the grave\" with the subthemes of \"organ as the God's deposit,\" \"God as the source of life,\" and \"new life\"; \"chapter of prosperity\" with the subthemes of \"the spring of the body,\" \"recovery,\" \"peace and joy,\" \"benevolent and good behavior,\" \"renewal,\" \"opportunity of being together again,\" \"golden age,\" \"positive perspective,\" \"the sense of normality,\" \"the return of health,\" and \"spiritual evolution\"; and \"the fall\" with the subthemes of \"a lack of energy,\" \"the mirage of transplantation,\" and \"hell on the earth.\"</p><p><strong>Conclusion: </strong>The patients had diverse experiences of the post-transplantation period, which varied from the feeling of exhilaration and youth to losing energy and the wish for not undertaking organ transplantation.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 2","pages":"88-96"},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37024370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Living Donor Re-transplantation for Repeated Acute Liver Failure. 反复急性肝衰竭的活体供体再移植。
IF 0.7 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-02-01
V Ince, C Kayaalp, E Otan, F Ozdemir, A Dirican, H I Toprak, C Aydin, C Ara, S Yilmaz

Emergency liver transplantation (LT) for acute liver failure (ALF) is a life-saving treatment. Occurrence of this situation in the same patient twice is very rare. Herein, we describe a patient who underwent two emergency LTs for ALF, both from living donors. When she was 26 years old, she underwent a right lobe living donor LT (LDLT) from her sister for ALF due to use of herbal weight loss medications. The next 3 years were uneventful but another ALF developed during a terminal stage pregnancy (37th week). Despite medical treatment, her liver functions worsened, and the baby was delivered by caesarean section. The second time, her brother was the donor and she recovered after the emergency right lobe re-LDLT. Both patient and baby were well at the 2-month follow-up. As far as we know, there is no reported similar case, and we concluded that LDLT is a paramount treatment option for both primary and secondary ALFs.

急性肝衰竭(ALF)的紧急肝移植(LT)是一种挽救生命的治疗方法。这种情况在同一患者中出现两次是非常罕见的。在此,我们描述了一位接受了两次ALF紧急lt的患者,均来自活体供体。当她26岁时,由于使用草药减肥药,她接受了姐姐的右叶活体肝移植(LDLT)治疗ALF。接下来的3年没有发生任何事情,但在妊娠晚期(第37周)又发生了一次ALF。尽管接受了治疗,但她的肝功能恶化,婴儿还是剖腹产了。第二次,她的哥哥是供体,她在紧急右肺再ldlt后康复。在2个月的随访中,患者和婴儿均表现良好。据我们所知,没有类似病例的报道,我们的结论是LDLT是原发性和继发性ALFs的首要治疗选择。
{"title":"Living Donor Re-transplantation for Repeated Acute Liver Failure.","authors":"V Ince,&nbsp;C Kayaalp,&nbsp;E Otan,&nbsp;F Ozdemir,&nbsp;A Dirican,&nbsp;H I Toprak,&nbsp;C Aydin,&nbsp;C Ara,&nbsp;S Yilmaz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Emergency liver transplantation (LT) for acute liver failure (ALF) is a life-saving treatment. Occurrence of this situation in the same patient twice is very rare. Herein, we describe a patient who underwent two emergency LTs for ALF, both from living donors. When she was 26 years old, she underwent a right lobe living donor LT (LDLT) from her sister for ALF due to use of herbal weight loss medications. The next 3 years were uneventful but another ALF developed during a terminal stage pregnancy (37<sup>th</sup> week). Despite medical treatment, her liver functions worsened, and the baby was delivered by caesarean section. The second time, her brother was the donor and she recovered after the emergency right lobe re-LDLT. Both patient and baby were well at the 2-month follow-up. As far as we know, there is no reported similar case, and we concluded that LDLT is a paramount treatment option for both primary and secondary ALFs.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 1","pages":"50-52"},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35908169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stem Cell-Based Therapies and Tissue Engineering of Trachea as Promising Therapeutic Methods in Mustard Gas Exposed Patients. 基于干细胞的治疗和气管组织工程是芥子气暴露患者的有前途的治疗方法。
IF 0.3 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-11-01
S P Khazraee, S M Marashi, M Kaviani, N Azarpira

Tissue engineering and cell-based therapies are promising therapeutic approaches in structural and functional defects of the trachea. Researchers have focused on these approaches to overcome the complications related to such diseases. Patients exposed to mustard gas suffer from massive damage to the respiratory system. Current treatment plans are only palliative and include anti-inflammatory drugs, broncholytics, long-acting β2-agonists, and inhaled corticosteroids. As mustard gas exposure leads to chronic airway inflammation, it seems that tracheobronchomalacia, because of chronic inflammation and weakness of the supporting cartilage, is an important factor in the development of chronic and refractory respiratory symptoms. The previous studies show that regenerative medicine approaches have promising potential to improve the life quality of patients suffering from tracheal defects. It seems that the engineered tracheal graft may improve the respiratory function and decrease symptoms in patients who suffer from asthma-like attacks due to mustard gas exposure. There are several successful case reports on the transplantation of stem cell-based bioartificial grafts in structural airway diseases. Therefore, we hope that the reconstruction of tracheobronchial structure can lead to a decrease in respiratory difficulties in mustard gas-exposed patients who suffer from tracheomalacia. In the present review, we summarize the main aspects of tracheal tissue engineering and cell-based therapies and the possibilities of the application of these approaches in mustard gas-exposed patients.

组织工程和基于细胞的治疗是治疗气管结构和功能缺陷的有前景的方法。研究人员专注于这些方法来克服与此类疾病相关的并发症。暴露在芥子气中的患者会对呼吸系统造成严重损害。目前的治疗计划只是姑息性的,包括抗炎药、支气管溶解药、长效β2-激动剂和吸入性皮质类固醇。由于芥子气暴露会导致慢性气道炎症,由于慢性炎症和支撑软骨无力,气管支气管软化症似乎是发展为慢性和难治性呼吸道症状的重要因素。先前的研究表明,再生医学方法在改善气管缺陷患者的生活质量方面具有很好的潜力。工程化气管移植物似乎可以改善因暴露于芥子气而患哮喘样发作的患者的呼吸功能并减轻症状。关于干细胞生物人工移植物在结构性气道疾病中的移植,已有几篇成功的案例报道。因此,我们希望气管支气管结构的重建能够减少暴露于芥子气的气管软化症患者的呼吸困难。在本综述中,我们总结了气管组织工程和基于细胞的治疗的主要方面,以及这些方法在芥子气暴露患者中应用的可能性。
{"title":"Stem Cell-Based Therapies and Tissue Engineering of Trachea as Promising Therapeutic Methods in Mustard Gas Exposed Patients.","authors":"S P Khazraee, S M Marashi, M Kaviani, N Azarpira","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Tissue engineering and cell-based therapies are promising therapeutic approaches in structural and functional defects of the trachea. Researchers have focused on these approaches to overcome the complications related to such diseases. Patients exposed to mustard gas suffer from massive damage to the respiratory system. Current treatment plans are only palliative and include anti-inflammatory drugs, broncholytics, long-acting β<sub>2</sub>-agonists, and inhaled corticosteroids. As mustard gas exposure leads to chronic airway inflammation, it seems that tracheobronchomalacia, because of chronic inflammation and weakness of the supporting cartilage, is an important factor in the development of chronic and refractory respiratory symptoms. The previous studies show that regenerative medicine approaches have promising potential to improve the life quality of patients suffering from tracheal defects. It seems that the engineered tracheal graft may improve the respiratory function and decrease symptoms in patients who suffer from asthma-like attacks due to mustard gas exposure. There are several successful case reports on the transplantation of stem cell-based bioartificial grafts in structural airway diseases. Therefore, we hope that the reconstruction of tracheobronchial structure can lead to a decrease in respiratory difficulties in mustard gas-exposed patients who suffer from tracheomalacia. In the present review, we summarize the main aspects of tracheal tissue engineering and cell-based therapies and the possibilities of the application of these approaches in mustard gas-exposed patients.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 4","pages":"145-154"},"PeriodicalIF":0.3,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409095/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41120785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of Histopathologic Findings of Post-reperfusion Liver Needle Biopsies. 肝再灌注后穿刺活检病理表现的价值。
IF 0.7 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-11-01
B Geramizadeh, M Hassani, K Kazemi, A R Shamsaifar, S A Malek-Hosseini

Background: Histopathologic changes of post-reperfusion liver needle biopsies in patients with liver transplantation have rarely been reported and most of the previous reports have been in less than 200 cases.

Objective: In this study, we evaluated 408 post-perfusion liver needle biopsies for the histopathologic changes attributable to reperfusion injury and compared them with early post-liver transplantation outcome, to find out the value of these findings.

Methods: In 408 patients who underwent liver transplantation, post-perfusion liver needle biopsy was taken within one hour of vascular anastomosis. The specimens were fixed in formalin and evaluated by a hepatopathologist blinded to the outcome of transplantation for hepatocellular necrosis, apoptosis, ballooning degeneration, cholestasis, neutrophilic infiltration, and steatosis. These were compared with cold and warm ischemic time, levels of AST, ALT, alkaline phosphatase, bilirubin, presence or absence of rejection, and duration of hospital stay.

Results: Hepatocellular ballooning degeneration, apoptosis, and necrosis did not show any significant correlations with early post-transplantation outcome and reperfusion injury. However, presence of neutrophilic infiltration in the post-reperfusion liver biopsy was well correlated with liver function tests and other clinical and paraclinical findings. Presence of steatosis in post-reperfusion liver needle biopsy was also associated with high liver function tests and long hospital stay.

Conclusion: Presence of PMN leukocytes in the post-perfusion liver needle biopsy of transplanted liver is associated with poor early outcome and reperfusion injury, so it should be recorded in the pathology report and should be considered a high-risk sign for the clinicians.

背景:肝移植患者再灌注后肝穿刺活检的组织病理学变化报道甚少,以往报道多在200例以下。目的:本研究对408例灌注后肝穿刺活检的再灌注损伤病理组织学改变进行评价,并与肝移植术后早期转归进行比较,探讨这些发现的价值。方法:408例肝移植患者在血管吻合后1小时内行灌注后肝穿刺活检。将标本固定在福尔马林中,由肝病理学家对移植后肝细胞坏死、凋亡、球囊变性、胆汁潴留、中性粒细胞浸润和脂肪变性的结果进行盲法评估。将这些数据与冷热缺血时间、AST、ALT、碱性磷酸酶、胆红素水平、是否存在排斥反应以及住院时间进行比较。结果:肝细胞球囊变性、凋亡和坏死与移植后早期预后和再灌注损伤无显著相关性。然而,再灌注后肝活检中中性粒细胞浸润的存在与肝功能检查和其他临床和临床旁发现密切相关。再灌注后肝穿刺活检中脂肪变性的存在也与肝功能检查结果高和住院时间长有关。结论:移植肝灌注后肝穿刺活检中出现PMN白细胞与早期预后差及再灌注损伤有关,应在病理报告中予以记录,临床医生应将其视为高危体征。
{"title":"Value of Histopathologic Findings of Post-reperfusion Liver Needle Biopsies.","authors":"B Geramizadeh,&nbsp;M Hassani,&nbsp;K Kazemi,&nbsp;A R Shamsaifar,&nbsp;S A Malek-Hosseini","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Histopathologic changes of post-reperfusion liver needle biopsies in patients with liver transplantation have rarely been reported and most of the previous reports have been in less than 200 cases.</p><p><strong>Objective: </strong>In this study, we evaluated 408 post-perfusion liver needle biopsies for the histopathologic changes attributable to reperfusion injury and compared them with early post-liver transplantation outcome, to find out the value of these findings.</p><p><strong>Methods: </strong>In 408 patients who underwent liver transplantation, post-perfusion liver needle biopsy was taken within one hour of vascular anastomosis. The specimens were fixed in formalin and evaluated by a hepatopathologist blinded to the outcome of transplantation for hepatocellular necrosis, apoptosis, ballooning degeneration, cholestasis, neutrophilic infiltration, and steatosis. These were compared with cold and warm ischemic time, levels of AST, ALT, alkaline phosphatase, bilirubin, presence or absence of rejection, and duration of hospital stay.</p><p><strong>Results: </strong>Hepatocellular ballooning degeneration, apoptosis, and necrosis did not show any significant correlations with early post-transplantation outcome and reperfusion injury. However, presence of neutrophilic infiltration in the post-reperfusion liver biopsy was well correlated with liver function tests and other clinical and paraclinical findings. Presence of steatosis in post-reperfusion liver needle biopsy was also associated with high liver function tests and long hospital stay.</p><p><strong>Conclusion: </strong>Presence of PMN leukocytes in the post-perfusion liver needle biopsy of transplanted liver is associated with poor early outcome and reperfusion injury, so it should be recorded in the pathology report and should be considered a high-risk sign for the clinicians.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 4","pages":"168-172"},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37224693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Hepatic Allograft Rejection in Pediatric Recipients: Effective Factors. 儿童肝移植急性排斥反应:影响因素。
IF 0.7 Q4 TRANSPLANTATION Pub Date : 2018-01-01 Epub Date: 2018-02-01
S M Dehghani, I Shahramian, M Afshari, M Bahmanyar, M Ataollahi, A Sargazi

Background: Acute cellular rejection (ACR), a reversible process, can affect the graft survival.

Objective: To evaluate the relation between ACR and clinical factors in recipients of allograft liver transplantation.

Methods: 47 recipients of liver were consecutively enrolled in a retrospective study. Their information were retrieved from their medical records and analyzed.

Results: Of the 47 recipients, 38 (81%) experienced acute rejection during 24 months of the transplantation. None of the studied factors for occurring transplant rejection, i.e., blood groups, sex, age, familial history of disease, receiving drugs and blood products, type of donor, Child score, and Child class, was not found to be significant.

Conclusion: During a limited follow-up period, we did not find any association between ACR and suspected risk factors.

背景:急性细胞排斥反应(ACR)是一个可逆的过程,可影响移植物的存活。目的:探讨同种异体肝移植受者ACR与临床因素的关系。方法:对47例肝移植受者进行回顾性研究。研究人员从他们的医疗记录中检索并分析了他们的信息。结果:47例受者中,38例(81%)在移植24个月内出现急性排斥反应。所研究的发生移植排斥反应的因素,即血型、性别、年龄、疾病家族史、接受药物和血液制品、供体类型、儿童评分和儿童类别,均未发现有显著性。结论:在有限的随访期间,我们未发现ACR与可疑危险因素之间存在任何关联。
{"title":"Acute Hepatic Allograft Rejection in Pediatric Recipients: Effective Factors.","authors":"S M Dehghani,&nbsp;I Shahramian,&nbsp;M Afshari,&nbsp;M Bahmanyar,&nbsp;M Ataollahi,&nbsp;A Sargazi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Acute cellular rejection (ACR), a reversible process, can affect the graft survival.</p><p><strong>Objective: </strong>To evaluate the relation between ACR and clinical factors in recipients of allograft liver transplantation.</p><p><strong>Methods: </strong>47 recipients of liver were consecutively enrolled in a retrospective study. Their information were retrieved from their medical records and analyzed.</p><p><strong>Results: </strong>Of the 47 recipients, 38 (81%) experienced acute rejection during 24 months of the transplantation. None of the studied factors for occurring transplant rejection, <i>i.e</i>., blood groups, sex, age, familial history of disease, receiving drugs and blood products, type of donor, Child score, and Child class, was not found to be significant.</p><p><strong>Conclusion: </strong>During a limited follow-up period, we did not find any association between ACR and suspected risk factors.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"9 1","pages":"41-45"},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839629/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35908167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Organ Transplantation Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1